Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Conditions

Breast Neoplasms 9476Neoplasms 6587Prostatic Neoplasms 4399Colorectal Neoplasms 3977Lung Neoplasms 3642Carcinoma, Non-Small-Cell Lung 3583Pancreatic Neoplasms 2478Carcinoma, Hepatocellular 2411Leukemia, Myeloid, Acute 2265Multiple Myeloma 2120Stomach Neoplasms 2108Neoplasm Metastasis 1911Head and Neck Neoplasms 1869Ovarian Neoplasms 1773Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1729Brain Neoplasms 1699Rectal Neoplasms 1676Melanoma 1654Colonic Neoplasms 1629Leukemia 1500Uterine Cervical Neoplasms 1499Recurrence 1485Esophageal Neoplasms 1311Glioblastoma 1307Lymphoma, Non-Hodgkin 1204Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

Ranibizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Conjunctival Neoplasms × Clear all
NCT05645341 2024-08-05

Artificial Intelligence-assisted Screening of Malignant Pigmented Tumors on the Ocular Surface

Sun Yat-sen University

Completed
535 enrolled

Conjunctival Neoplasms, Eye Neoplasms, Orbital Neoplasms

NCT03515954 2019-01-02

AS-OCT Guided Treatment of Diffuse CSCC

Benha University

Completed
15 enrolled

Conjunctival Neoplasms

NCT00456495 2017-07-21

Effect of Ranibizumab on Malignant Conjunctival Neoplasia

The New York Eye Cancer Center

Phase 1 Completed
5 enrolled 6 charts

Conjunctival Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡